4.6 Article

T Regulatory Cells in Autoimmune Diabetes: Past Challenges, Future Prospects

Journal

JOURNAL OF CLINICAL IMMUNOLOGY
Volume 28, Issue 6, Pages 677-684

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-008-9242-z

Keywords

Tregs; diabetes; autoimmunity; Foxp3

Categories

Ask authors/readers for more resources

Introduction Accumulating evidence suggests that defective regulation is an essential underlying cause of autoimmunity. The development of type I diabetes in the NOD mouse strain it is a complex process that depends on a fine balance between pathogenic and regulatory pathways. Discussion We have utilized a series of transgenic and knockout mice to determine the relative importance of regulatory T cells and negative regulatory receptors on the development and progression of type I diabetes. Conclusion This review will focus on the origins and function of Treg in peripheral self-tolerance. We will summarize the role of Treg in preventing autoimmune diseases, with a particular focus on Type 1 Diabetes (T1D), and discuss the prospects for Treg-based therapies for autoimmune diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available